Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
8,027,918
-
Share change
-
+376,222
-
Total reported value
-
$64,978,460
-
Put/Call ratio
-
111%
-
Price per share
-
$8.08
-
Number of holders
-
57
-
Value change
-
+$2,852,927
-
Number of buys
-
30
-
Number of sells
-
17
Institutional Holders of REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) as of Q4 2020
As of 31 Dec 2020,
REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,027,918 shares.
The largest 10 holders included
DISCIPLINED GROWTH INVESTORS INC /MN, Ibex Investors LLC, Migdal Insurance & Financial Holdings Ltd., Creative Planning, BlackRock Inc., GAGNON SECURITIES LLC, ARK Investment Management LLC, WELLS FARGO & COMPANY/MN, Sculptor Capital LP, and GOLDMAN SACHS GROUP INC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.